InVivo Therapeutics Holdings Price to Sales Ratio 2010-2023 | NVIVQ
Historical PS ratio values for InVivo Therapeutics Holdings (NVIVQ) over the last 10 years. The current P/S ratio for InVivo Therapeutics Holdings as of May 02, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| InVivo Therapeutics Holdings P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-07-19 | 0.37 | 0.00 | |
| 2023-09-30 | 1.12 | 0 | 0.00 |
| 2023-06-30 | 1.35 | 0 | 0.00 |
| 2023-03-31 | 1.06 | 0 | 0.00 |
| 2022-12-31 | 2.35 | 0 | 0.00 |
| 2022-09-30 | 4.29 | 0 | 0.00 |
| 2022-06-30 | 4.05 | 0 | 0.00 |
| 2022-03-31 | 8.75 | 0 | 0.00 |
| 2021-12-31 | 11.50 | 0 | 0.00 |
| 2021-09-30 | 17.50 | 0 | 0.00 |
| 2021-06-30 | 18.50 | 0 | 0.00 |
| 2021-03-31 | 24.75 | 0 | 0.00 |
| 2020-12-31 | 20.25 | 0 | 0.00 |
| 2020-09-30 | 35.50 | 0 | 0.00 |
| 2020-06-30 | 39.50 | 0 | 0.00 |
| 2020-03-31 | 42.25 | 0 | 0.00 |
| 2019-12-31 | 165.00 | 0 | 0.00 |
| 2019-09-30 | 375.00 | 0 | 0.00 |
| 2019-06-30 | 555.00 | 0 | 0.00 |
| 2019-03-31 | 1162.50 | 0 | 0.00 |
| 2018-12-31 | 1132.50 | 0 | 0.00 |
| 2018-09-30 | 1515.00 | 0 | 0.00 |
| 2018-06-30 | 1275.00 | 0 | 0.00 |
| 2018-03-31 | 10125.00 | 0 | 0.00 |
| 2017-12-31 | 14437.50 | 0 | 0.00 |
| 2017-09-30 | 27187.50 | 0 | 0.00 |
| 2017-06-30 | 50625.00 | 0 | 0.00 |
| 2017-03-31 | 75937.50 | 0 | 0.00 |
| 2016-12-31 | 78750.00 | 0 | 0.00 |
| 2016-09-30 | 127500.00 | 0 | 0.00 |
| 2016-06-30 | 108375.00 | 0 | 0.00 |
| 2016-03-31 | 130875.00 | 0 | 0.00 |
| 2015-12-31 | 135000.00 | 0 | 0.00 |
| 2015-09-30 | 161625.00 | 0 | 0.00 |
| 2015-06-30 | 302812.00 | 0 | 0.00 |
| 2015-03-31 | 222750.00 | 0 | 0.00 |
| 2014-12-31 | 99000.00 | 0 | 0.00 |
| 2014-09-30 | 42000.00 | 0 | 0.00 |
| 2014-06-30 | 78000.00 | 0 | 0.00 |
| 2014-03-31 | 132000.00 | 0 | 0.00 |
| 2013-12-31 | 172500.00 | 0 | 0.00 |
| 2013-09-30 | 107250.00 | 0 | 0.00 |
| 2013-06-30 | 309750.00 | 0 | 0.00 |
| 2013-03-31 | 179250.00 | 0 | 0.00 |
| 2012-12-31 | 130500.00 | 0 | 0.00 |
| 2012-09-30 | 116250.00 | 0 | 0.00 |
| 2012-06-30 | 171750.00 | 0 | 0.00 |
| 2012-03-31 | 186000.00 | 0 | 0.00 |
| 2011-12-31 | 206250.00 | 0 | 0.00 |
| 2011-09-30 | 49500.00 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.000B | $0.000B |
| InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible polymer scaffolding device to treat acute wound SCI; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute SCI; and a biocompatible polymer scaffolding device seeded with autologous hNSCs to treat acute and chronic SCI. InVivo Therapeutics Holdings Corp. is based in Cambridge, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.085B | 27.79 |
| Boston Scientific (BSX) | United States | $155.238B | 38.86 |
| Stryker (SYK) | United States | $144.362B | 30.18 |
| EssilorLuxottica (ESLOY) | France | $132.860B | 0.00 |
| Medtronic (MDT) | Ireland | $108.824B | 15.89 |
| Lonza Group Ag (LZAGY) | Switzerland | $52.624B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.259B | 27.44 |
| ResMed (RMD) | United States | $35.183B | 26.43 |
| GE HealthCare Technologies (GEHC) | United States | $32.295B | 15.33 |
| Agilent Technologies (A) | United States | $30.971B | 20.46 |
| Terumo (TRUMY) | Japan | $29.019B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $24.053B | 17.17 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.255B | 12.80 |
| Insulet (PODD) | United States | $18.084B | 77.18 |
| Baxter (BAX) | United States | $15.752B | 11.77 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.535B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.970B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.447B | 18.31 |
| Bio-Rad Laboratories (BIO) | United States | $6.620B | 22.38 |
| Prestige Consumer Healthcare (PBH) | United States | $4.171B | 19.90 |
| Perrigo (PRGO) | Ireland | $3.497B | 10.01 |
| ICU Medical (ICUI) | United States | $3.486B | 29.69 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.208B | 15.10 |
| Envista Holdings (NVST) | United States | $2.880B | 23.93 |
| GN Store Nord (GNNDY) | Denmark | $2.068B | 17.13 |
| QuidelOrtho (QDEL) | United States | $1.964B | 16.45 |
| LeMaitre Vascular (LMAT) | United States | $1.778B | 39.75 |
| AtriCure (ATRC) | United States | $1.486B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.374B | 21.63 |
| Neogen (NEOG) | United States | $1.248B | 15.97 |
| Kestra Medical Technologies (KMTS) | United States | $1.220B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.200B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.184B | 11.40 |
| InMode (INMD) | Israel | $1.013B | 9.28 |
| Phibro Animal Health (PAHC) | United States | $0.789B | 12.10 |
| Evolus (EOLS) | United States | $0.779B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.637B | 0.00 |
| CeriBell (CBLL) | United States | $0.588B | 0.00 |
| Owens & Minor (OMI) | United States | $0.580B | 4.94 |
| Valneva SE (VALN) | France | $0.549B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.542B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.526B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.458B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.442B | 0.00 |
| Omeros (OMER) | United States | $0.418B | 0.00 |
| Surmodics (SRDX) | United States | $0.395B | 0.00 |
| SNDL (SNDL) | Canada | $0.365B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.359B | 15.55 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.296B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.292B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.291B | 26.32 |
| Aurora Cannabis (ACB) | Canada | $0.272B | 48.40 |
| Sanuwave Health (SNWV) | United States | $0.264B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 15.60 |
| Cerus (CERS) | United States | $0.258B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.245B | 0.00 |
| Quanterix (QTRX) | United States | $0.233B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.231B | 0.00 |
| High Tide (HITI) | Canada | $0.194B | 0.00 |
| Biote (BTMD) | United States | $0.190B | 4.35 |
| Utah Medical Products (UTMD) | United States | $0.173B | 13.93 |
| Brainsway (BWAY) | Israel | $0.170B | 53.06 |
| TriSalus Life Sciences (TLSI) | United States | $0.165B | 0.00 |
| Organigram Global (OGI) | Canada | $0.154B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.148B | 18.22 |
| Jin Medical (ZJYL) | China | $0.119B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.116B | 0.00 |
| MacroGenics (MGNX) | United States | $0.110B | 0.00 |
| Exagen (XGN) | United States | $0.108B | 0.00 |
| Agape ATP (ATPC) | $0.099B | 0.00 | |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.70 |
| Jushi Holdings (JUSHF) | United States | $0.076B | 0.00 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Zynex (ZYXI) | United States | $0.070B | 0.00 |
| United Health Products (UEEC) | United States | $0.064B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Apyx Medical (APYX) | United States | $0.047B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.042B | 61.50 |
| United-Guardian (UG) | United States | $0.037B | 11.28 |
| Safety Shot (SHOT) | United States | $0.036B | 0.00 |
| Nephros (NEPH) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |